Importantly, the transient inhibition of JAK2 helped to control massive cytokine release, preserve liver integrity, and did not interfere with the potent anti-tumor activity of L19-mIL12 and its immunological effects at the neoplastic site. Here, JAK2 is linked to neoplasm.